Defining Patient-Important Outcomes after Pediatric Hematopoietic Stem Cell Transplant

Taylor Fitch(University of Cincinnati Medical Center), Christopher E. Dandoy(Cincinnati Children's Hospital Medical Center), Ahna L. H. Pai(University of Cincinnati Medical Center), Seth Rotz(Cleveland Clinic), Kaitlyn Kusnier(Cincinnati Children's Hospital Medical Center), Kasiani C. Myers(Immune Deficiency Foundation), Nicole Liberio(Children's Hospital of Wisconsin), Leslie Lehmann(Harvard University), Therese Dodd(Sarah Cannon), Loretta Parker(University of Oklahoma Medical Center), Melissa Hayward, Jeffery James Auletta, Audrey M. Sigmund(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Sagar S. Patel(University of Utah), Mark Mueller(University of Cincinnati Medical Center), David Hartley(Cincinnati Children's Hospital Medical Center), Neel S. Bhatt(The Ohio State University Wexner Medical Center), M. Christa Krupski, Laura Flesch(University of Cincinnati Medical Center), Christine Sper(University of Cincinnati Medical Center), Malika Kapadia(Harvard University), John Huber(Canadian Forest Service), Sarah Tarquini(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Samantha Jaglowski(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Kimberly Craig, Joseph Maakaron(The Ohio State University), Rita Jakubowski(Children's Hospital of Wisconsin), Rachel Phelan(Children's Hospital of Wisconsin), Julie Porter, Kathleen Marie Demmel, Alison Neal, Robyn Blacken(Dana-Farber/Boston Children's Cancer and Blood Disorders Center)
Transplantation and Cellular Therapy
March 1, 2022
Cited by 0


Related Papers